Extraordinary Claims Without Extraordinary Evidence: Controversy on Anti-Androgen Therapy for COVID-19

    March 2021 in “ Journal of the European Academy of Dermatology and Venereology ”
    Ralph M. Trüeb, Antonia Régnier, N. Caballero-Uribe … Hudson Dutra Rezende
    Studysummary This letter to the editor discusses the controversy surrounding the use of anti-androgen therapy for COVID-19 without providing new clinical evidence, and calls for caution in making extraordinary claims.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Comment on: The Gabrin Sign Journal of The American Academy of Dermatology · 2020
    2. 5-Alpha-Reductase Inhibitors Are Associated With Reduced Frequency of COVID-19 Symptoms in Males With Androgenetic Alopecia Journal of The European Academy of Dermatology and Venereology · 2020
    3. Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19' Journal of The American Academy of Dermatology · 2020
    4. Androgenetic Alopecia in COVID-19: Compared to What? Journal of The American Academy of Dermatology · 2020
    5. Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign Journal of The American Academy of Dermatology · 2020
    6. Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign' Journal of The American Academy of Dermatology · 2020
    7. A Preliminary Observation: Male Pattern Hair Loss Among Hospitalized COVID-19 Patients in Spain – A Potential Clue to the Role of Androgens in COVID-19 Severity Journal of Cosmetic Dermatology · 2020
    8. What Does Androgenetic Alopecia Have to Do with COVID-19? An Insight into a Potential New Therapy Dermatologic Therapy · 2020

    Related research 1

    1. Extraordinary Claims Without Extraordinary Evidence: Controversy on Anti-Androgen Therapy for COVID-19 Journal of the European Academy of Dermatology and Venereology · 2021